PCM
GEVA

Prelude Capital Management’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Prelude Capital Management’s Portfolio GEVA Stock Details GEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-6,638
Closed -$551K – 2173
2014
Q1 		$551K Buy
6,638
+4,058
+157% +$337K 0.07% 314
2013
Q4 		$167K Buy
2,580
+20
+0.8% +$1.3K 0.03% 606
2013
Q3 		$162K Buy
+2,560
New +$162K 0.03% 523